Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -66.90x is 1106% below its 3-year average of -5.55x, near the low end of its 3-year range (-66.90x–0.05x).
2044.59% below its 12-month average of -3.12x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2025-09-30): -1.15x.
INTEREST COVERAGE RATIO
-66.90x
INTEREST COVERAGE RATIO AVG TTM
-3.12x
INTEREST COVERAGE RATIO AVG 3Y
-5.55x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2044.59%
CURRENT VS 3Y AVG
-1105.77%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
-1492.86%
vs the sector median at left
Alps Group Inc
Market Cap
$66.56M
Interest Coverage Ratio
-66.90x
TTM Avg
-3.12x
3Y Avg
-5.55x
5Y Avg
N/A
Market Cap
$67.11M
Interest Coverage Ratio
-5.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$65.08M
Interest Coverage Ratio
-14.86x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$64.56M
Interest Coverage Ratio
0.34x
TTM Avg
0.34x
3Y Avg
1.90x
5Y Avg
3.13x
Market Cap
$69.05M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$63.98M
Interest Coverage Ratio
-21.57x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$69.43M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$70.01M
Interest Coverage Ratio
N/A
TTM Avg
933.58x
3Y Avg
933.58x
5Y Avg
933.58x
Market Cap
$70.03M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $66.56M | -66.90x | -3.12x | -5.55x | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | -5.91x | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | -14.86x | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $64.56M | 0.34x | 0.34x | 1.90x | 3.13x |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | N/A | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $63.98M | -21.57x | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | -8.06x | N/A | N/A | N/A |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | N/A | 933.58x | 933.58x | 933.58x |
| Heron Therapeutics, Inc. (HRTX)vs › | $70.03M | N/A | N/A | N/A | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.77M | -31.98x | N/A | N/A | N/A |
Interest Coverage
-66.9x
Debt/Equity
N/A
Current Ratio
0.36
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-09-30 | -1.15x |
| 2025-09-30 | -1.15x |
| 2025-06-30 | -1.00x |
| 2025-03-31 | -1.70x |
| 2024-12-31 | -7.21x |
| 2024-09-30 | -6.52x |
| 2024-06-30 | -10.77x |
| 2024-03-31 | -17.95x |
| 2023-12-31 | -13.66x |
| 2023-03-31 | 0.05x |
| 2022-12-31 | 0.02x |
